1:45 p.m. - Welcome by Ronald Kaplan, PhD, EVP, Research
1:55 p.m. - Overview of Brain Science Institute by Jeremy Amiel Rosenkranz, PhD, Director
2:10 p.m. - “Alzheimer’s Disease – Cure or Prevent?” by Arthur Levine MD, Executive Director of Brain Institute, University of Pittsburgh
2:50 p.m. - Neurodegenerative Diseases Panel
Moderator:Grace Stutzmann, PhD, Associate Professor & Director, Center for Neurodegenerative Diseases and Therapeutics, Foundational Sciences and Humanities, Neuroscience Chicago Medical School, School of Graduate and Postdoctoral Studies
Robert Marr, PhD, Associate Professor & Assistant Dean for Research, Foundational Sciences and Humanities, Neuroscience Chicago Medical School, School of Graduate and Postdoctoral Studies
Sarah Johnson, PhD, Assistant Professor of Neuroscience, Center for Neurodegenerative Diseases and Therapeutics
Nicole Bjorklund, PhD, Assistant Director, Scientific Affairs at Alzheimer's Drug Discovery Foundation
Heather Snyder, PhD, Vice President, Medical & Scientific Relations, Alzheimer's Association
Eric Karran, PhD, Vice President, Distinguished Research Fellow, Foundational Neuroscience Center, AbbVie
Phyllis Ferrell, MBA, Global Head, External Engagement Alzheimer's Disease and Neurodegeneration, Eli Lilly and Company
Moderator:Janice Urban, PhD, Director, Center for Neurobiology of Stress Resilience and Psychiatric Disorders; Professor and Discipline Chair, Physiology and Biophysics
Joanna Dabrowska, PhD, PharmD, Associate Professor, Foundational Sciences and Humanities, Cellular and Molecular Pharmacology, Neuroscience Chicago Medical School, School of Graduate and Postdoctoral Studies
Anthony Peterson, PsyD, Section Chief, PTSD Programs at Department of Veterans Affairs
Jeffrey Borenstein, MD, President and CEO, Brain & Behavior Research Foundation
Sanjay J. Mathew, MD, Marjorie Bintliff Johnson and Raleigh White Johnson, Jr. Vice Chair for Research and Professor in the Menninger Department of Psychiatry & Behavioral Sciences at Baylor College of Medicine
Christian Thomsen, PhD, PharmD, Global Head, CNS Business Development & Licensing, Boehringer Ingelheim
4:55 p.m. - Closing Remarks by Jeremy Amiel Rosenkranz, PhD, Director
5:00 p.m. - Networking
Day Two - 9/17/2020
1:45 p.m. - Welcome by Archana Chatterjee, MD, PhD, Dean of Chicago Medical School
1:50 p.m. - New Nucleic Acid-based Therapeutic Approaches in Neurological Disease by Michelle Hastings, PhD
2:10 p.m. - Therapeutic Innovation in CNS Disease by Norbert G. Riedel, PhD, President & Chief Executive Officer, Aptinyx
Moderator:William Frost, PhD, Director, Stanson Toshok Center for Brain Function and Repair; Professor & Discipline Chair, Cell Biology and Anatomy, Chicago Medical School, School of Graduate and Postdoctoral Studies
Michelle Hastings, PhD, Professor & Director, Center for Genetic Diseases, Chicago Medical School, School of Graduate and Postdoctoral Studies
Jonathan Pollock, PhD, MS, Chief, Genetics and Epigenetics, and Developmental Neuroscience Research Branch, National Inst. on Drug Abuse at NIH
Eun Jung Hwang, PhD, Assistant Professor of Cell Biology and Anatomy, Stanson Toshok Center for Brain Function and Repair
Terre A. Constantine, PhD, Executive Director and CEO, Brain Research Foundation
